CAH Forensic analysis

Trading Setup & Entry Strategy

• >Entry Zone: $190.00 - $192.00. This aligns with the 200-day SMA ($191.31) and the recent congestion area. Accumulate 50% here.
• >Add Level: $181.00 (Lower Bollinger Band support). Add remaining 50%.
• >Stop Loss: $178.00 (Hard stop). A breach below the lower Bollinger Band suggests a structural breakdown of the bullish recovery.
• >Take Profit: $209.50 (Upper Bollinger Band) and $215.00 (Psychological resistance/recent highs).
• >Risk/Reward: ~1:2.5.

Executive Summary

Cardinal Health (CAH) is currently navigating a transition characterized by aggressive M&A in the MSO space (Solaris, GIA), which has significantly expanded revenue (+17% YTD) but pressured margins through integration costs and a $184M goodwill impairment in the Navista & ION unit. While the stock shows bullish MACD momentum, the bearish 50/200 SMA cross and recent price rejection at the 50-day SMA suggest a tactical 'Hold' or 'Buy-on-pullback' stance. Analysis Date: 2026-05-20.

Recent Material Events (8-K Analysis)

• >2026-04-30: Regular reporting of corporate updates.
• >2026-03-23/03-05: Standard regulatory filings and procedural updates confirming operational continuity following the Solaris integration.

Insider Trading Activity

• >Recent Form 4 filings (Feb-April 2026) show standard RSU/PSU vestings. No significant open-market net buying or selling spikes by key executives (Hollar/Alt), suggesting a wait-and-see sentiment from the C-suite.

Business Model Analysis

• >Revenue Mix: Shift toward MSO platforms (specialty/urology/gastro) is driving top-line growth but complicates the cost structure.
• >Pricing Power: Pricing remains a critical headwind, particularly with the transition from IEEPA to Section 122 tariffs. Dependence on GLP-1 volumes is high, but margin contribution is negligible.

Financial Health

Technical Analysis & Trade Timing

• >Trend: Bearish Crossing. The 50-day SMA ($205.43) sits above the 200-day SMA ($191.31), signaling a defensive posture.
• >Momentum: RSI 52.79 is neutral; MACD is bullish, suggesting a potential short-term bounce, but overall trend is indecisive.
• >Strategy: Respect the 200-day SMA as the ultimate floor. Avoid chasing near current $200 levels; wait for the test of the $190 area.

Short-Term Trading Strategy (2-5 Days)

• >Timeframe: Swing Trade (2–5 Days)
• >Position Size: 3% of portfolio.
• >Max Hold: 10 Days.
• >Risk: Volatility from IEEPA tariff refund uncertainty.

One-Liner Thesis: CAH is a structural growth story obscured by M&A noise and tariff uncertainty; technicals favor buying only upon a return to long-term mean support at $191.